RSII News 08/29/2014 16:28:11 $RSII Tuesday pre market

New Post Public Reply Private Reply Replies (0) Message Board
Jake13
RSII News 08/29/2014 16:28:11 $RSII
Tuesday pre market would be a great time to release news. That way we could run all week. All the way to .05/sh
They gotta be wayyy short. Getting another 2 mill monday

RSII Stock Message Board http://investorshangout.com/Rising-India-Inc-RSII-66300/

Awesome response! $RSII is going to be very exciting next week.
Email Response from CEO $RSII


Big week next week
Heckofa day... $.0047 Close woulda been Awesome!!!
FLYING AWAY TUESDAY IMO
Is there gonna b news coming next week.
Interest spike over long weekend I mean
Will see interest build out there. This is one of the better stocks out there
Yeah i think the 3day weekend had a lot to do with it. A lot if people only work 1-2hours today and start vacation early
Closed at .0034. Decent for a Friday but far less that I hoped for when we hit .004 by 10:30. Now have to wait 3 days...
Damn I knew that, habit to say Monday lol
Open tue at .004 imo
Agree. Still setting up for the big run here imo but we'll see.

Long weekend doesn't help. If this was a weekday I think we may have broken 004.

You never know, but still much to look forward to I believe. Holding a bunch
Day traders exiting for long weekend and basic consolidation strong. It is a given it will move up though
LOL...Monday is a holiday. Have to wait til Tuesday.
Disagree. Would be nice, but wouldn't say we "need" it imo. Any close around here is great
Anything over .0037 would be perfect but hey even .0035 close won't be bad. Next week is when it gets really exciting $RSII
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Triumph Financial Sets Stage for Q4 Earnings and Insights

Updated Category News Views 196

Triumph Financial Plans Fourth Quarter Earnings Release Triumph Financial, Inc. (Nasdaq: TFIN) recently announced its anticipation for the release of fourth quarter financial results. This event is scheduled to take place after the market closes on an upcoming Wednesday. Along with the financial report, the company will provide management commentary for stakeholders and...

Continue Reading
Monitoring ABA Therapy Progress: A Parent's Guide

Updated Category News Views 6

The Nuts and Bolts of Progress Monitoring You've got a situation in Leominster where parents are trying to make sense of ABA therapy's impact on their kids. Rob Shapiro, a big name in the ABA world, breaks it all down in a HelloNation article. We're talking about precise data collection being the backbone of measuring progress in ABA therapy. This ain't no place for...

Continue Reading
Understanding Dowlais Group's Recent Market Activities

Updated Category News Views 185

Public Disclosure Regarding Dowlais Group's Trading Activity FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code 1. KEY INFORMATION (a) Name of exempt principal trader: Investec Bank plc (b) Name of offeror/offeree in relation to whose r

Continue Reading
OFS Credit Company Reports Impressive Q4 Financials for 2024

Updated Category News Views 98

OFS Credit Company Delivers Strong Q4 2024 Financial Results OFS Credit Company, Inc. (NASDAQ: OCCI), a notable investment firm focusing on collateralized loan obligation (CLO) equity and debt securities, has announced its financial performance for the fiscal quarter ending October 31, 2024. This report outlines the company’s significant financial growth and strategic...

Continue Reading
Breakthrough Data on HBI-8000 and Nivolumab for Melanoma

Updated Category News Views 89

HBI-8000 and Nivolumab: A New Era in Melanoma Treatment Recent findings highlight the potential of HBI-8000 in combination with nivolumab, suggesting a transformative approach in the treatment of advanced melanoma. This promising combination will be discussed in detail at an upcoming prestigious annual meeting focused on advancements in immunotherapy. Innovative Solutions...

Continue Reading